Are you Dr. Lalani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
# DANA1230
Boston, MA 02215Phone+1 617-632-5456
Publications & Presentations
PubMed
- 148 citationsMetabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, David A. Braun, Sachet A. Shukla
Nature Communications. 2019-09-25 - 62 citationsEffect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé
European Urology Oncology. 2020-06-01 - 51 citationsDurable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.Dylan J. Martini, Lana Hamieh, Rana R. McKay, Lauren C. Harshman, Raphael Brandao
Cancer Immunology Research. 2018-01-01
Press Mentions
Avelumab in Advanced Urothelial Carcinoma: Further Study Needed to Clarify Its RoleFebruary 10th, 2018
